Minority investor WaterMill succeeds in activist attack of Ziopharm, winning two board seats and removal of chairman
The activist attack launched at Ziopharm Oncology $ZIOP that turned into an ugly and bitter public feud has come to a conclusion.
Two of the three board nominees put forth by 3.3% minority investor WaterMill Asset Management Corp. will be joining Ziopharm’s board after receiving the necessary 50%+ votes from shareholders, WaterMill said Thursday morning. Additionally, a majority of Ziopharm shareholders voted to recall chairman Scott Tarriff, the firm said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.